Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / House Bills / H.R. 3839

H.R. 3839

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Print stageDateSize⠃
Introduced in House2023-06-063.9K⠃⠗⠋